Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Pollen Allergenic Extract [EPC]
Populus Alba Pollen is a non-standardized allergenic extract used primarily for the diagnosis and treatment of allergic rhinitis and asthma triggered by White Poplar pollen. It belongs to the class of Non-Standardized Pollen Allergenic Extracts.
Name
Populus Alba Pollen
Raw Name
POPULUS ALBA POLLEN
Category
Non-Standardized Pollen Allergenic Extract [EPC]
Drug Count
30
Variant Count
32
Last Verified
February 17, 2026
About Populus Alba Pollen
Populus Alba Pollen is a non-standardized allergenic extract used primarily for the diagnosis and treatment of allergic rhinitis and asthma triggered by White Poplar pollen. It belongs to the class of Non-Standardized Pollen Allergenic Extracts.
Detailed information about Populus Alba Pollen
References used for this content
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Populus Alba Pollen.
Populus Alba Pollen, derived from the White Poplar tree (also known as the silver poplar), is a biological substance used in clinical immunology. It belongs to a class of drugs known as Non-Standardized Pollen Allergenic Extracts [EPC]. These extracts are complex mixtures of proteins, glycoproteins, and polysaccharides harvested from the male catkins of the Populus alba tree. In the realm of clinical pharmacology, these extracts are not 'drugs' in the traditional synthetic sense but are biological products regulated by the FDA's Center for Biologics Evaluation and Research (CBER).
Historically, the use of pollen extracts dates back to the early 20th century, with Leonard Noon's pioneering work in 1911. Populus Alba Pollen extracts are utilized for two primary clinical purposes: the diagnosis of Type I hypersensitivity (allergic reactions) through skin testing and the treatment of these allergies through Allergen Immunotherapy (AIT), also known as hyposensitization or 'allergy shots.' As a non-standardized extract, its potency is typically measured in Protein Nitrogen Units (PNU) or weight/volume (w/v) ratios, rather than the Bioequivalent Allergy Units (BAU) seen in standardized extracts like those for grass or dust mites.
To understand how Populus Alba Pollen works, one must distinguish between its diagnostic and therapeutic mechanisms. At the molecular level, the extract contains specific allergenic proteins that cross-link with immunoglobulin E (IgE) antibodies bound to the surface of mast cells and basophils in sensitive individuals.
Diagnostic Mechanism: When a small amount of Populus Alba Pollen extract is introduced into the skin (epicutaneous or intradermal), it triggers a localized allergic response in sensitized patients. If the patient has specific IgE antibodies for White Poplar, the allergen binds to these antibodies, causing the mast cells to degranulate. This releases inflammatory mediators such as histamine, leukotrienes, and prostaglandins, resulting in a 'wheal and flare' reaction—a raised bump surrounded by redness. This allows healthcare providers to confirm a patient's sensitivity to this specific tree pollen.
Therapeutic Mechanism (Immunotherapy): When used in immunotherapy, the mechanism is far more complex and involves a fundamental reprogramming of the immune system. The goal is to induce 'immunological tolerance.' Repeated, escalating doses of the Populus Alba Pollen extract shift the immune response from a Th2-dominated profile (which promotes IgE production and allergic inflammation) to a Th1-dominated profile. This process stimulates the production of 'blocking antibodies,' specifically IgG4. These IgG4 antibodies compete with IgE for the allergen, effectively neutralizing the pollen before it can trigger an allergic reaction. Furthermore, immunotherapy induces the expansion of Regulatory T-cells (Tregs), which secrete inhibitory cytokines like IL-10 and TGF-beta, suppressing the overall allergic cascade.
Unlike conventional small-molecule drugs, the pharmacokinetics of allergenic extracts like Populus Alba Pollen do not follow standard absorption, distribution, metabolism, and excretion (ADME) models. Because it is a biological protein mixture administered locally (subcutaneously), its 'metabolism' is actually a series of immunological interactions.
Populus Alba Pollen extract is FDA-approved for the following indications:
Off-label uses are rare, though it may occasionally be included in broader 'tree mix' panels for research into cross-reactivity between members of the Salicaceae family (poplars and willows).
Populus Alba Pollen is available in several specialized formulations, typically concentrated in multidial vials:
> Important: Only your healthcare provider can determine if Populus Alba Pollen is right for your specific condition. The selection of the appropriate concentration and form is a critical clinical decision based on your sensitivity level.
Dosage for Populus Alba Pollen is highly individualized and must be determined by an allergist or immunologist based on the patient's skin test reactivity and clinical history. There is no 'standard' dose because it is a non-standardized extract.
Immunotherapy follows a two-phase schedule:
Populus Alba Pollen is generally considered safe for use in children, typically starting at age 5. Dosing protocols for children are identical to adult protocols in terms of concentration and escalation; however, healthcare providers may exercise greater caution during the build-up phase. Use in children under age 5 is generally avoided due to the difficulty of communicating systemic symptoms and the higher risk of respiratory distress.
No dosage adjustments are required for patients with renal impairment, as the clearance of allergenic proteins does not depend on kidney function.
No dosage adjustments are required for patients with hepatic impairment, as the liver does not metabolize these biological extracts.
Elderly patients (over 65) may require more cautious dosing, particularly if they have underlying cardiovascular disease. The risk-benefit ratio must be carefully weighed, as the ability to tolerate epinephrine (the treatment for a severe reaction) may be compromised in this population.
Populus Alba Pollen extracts are strictly for professional use and should never be self-administered.
If a dose is missed during the build-up phase, the next dose may need to be reduced or the previous dose repeated, depending on the length of the delay. If a dose is missed during the maintenance phase:
An 'overdose' in the context of immunotherapy refers to the administration of a dose that exceeds the patient's current tolerance level. This can occur due to a clerical error or if the patient's sensitivity has increased (e.g., during peak pollen season).
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or skip appointments without medical guidance, as this increases the risk of a severe reaction.
Most patients undergoing immunotherapy with Populus Alba Pollen will experience local reactions. These are generally not dangerous but can be uncomfortable.
> Warning: Stop taking Populus Alba Pollen and call your doctor immediately or seek emergency care if you experience any of these symptoms of anaphylaxis.
There are no known long-term 'toxic' effects of Populus Alba Pollen extract. Unlike steroids or other medications, these are biological proteins that do not accumulate in the body. The primary long-term risk is the development of new sensitivities, though immunotherapy often prevents the development of new allergies (the 'allergic march'). Some patients may experience persistent subcutaneous nodules (small lumps under the skin) at injection sites, which are usually benign and resolve over months.
While Populus Alba Pollen may not have a specific individual black box warning for every brand, the entire class of Allergenic Extracts carries a general FDA-mandated warning regarding Anaphylaxis.
Report any unusual symptoms to your healthcare provider. Even a late-onset reaction (occurring several hours after the injection) should be reported before your next scheduled dose.
Populus Alba Pollen is a potent biological agent. Its use is restricted to clinical settings where emergency resuscitation equipment is available. The most critical safety factor is the patient's current health status; injections should be postponed if the patient is suffering from an acute infection, high fever, or an exacerbation of asthma symptoms.
No specific FDA black box warning exists uniquely for Populus Alba Pollen, but it falls under the class-wide warning for all allergenic extracts regarding the risk of severe systemic reactions. Healthcare providers must ensure that patients are not 'high risk' (e.g., those with a FEV1 < 70% of predicted) before administration.
Generally, Populus Alba Pollen does not cause drowsiness. However, if a patient experiences a systemic reaction or receives epinephrine, they should not drive or operate machinery until cleared by a physician. Some patients may feel slightly lightheaded or fatigued after an injection and should wait until they feel fully alert.
There is no direct chemical interaction between alcohol and Populus Alba Pollen. However, alcohol consumption can increase blood flow to the skin (vasodilation) and may theoretically speed up the absorption of the allergen, potentially increasing the risk of a reaction. It is advised to avoid alcohol for several hours before and after an injection.
Immunotherapy is typically discontinued if:
There is no 'withdrawal' syndrome associated with stopping pollen extracts, but the patient's allergy symptoms will likely return over time if the course was not completed.
> Important: Discuss all your medical conditions, especially respiratory or heart problems, with your healthcare provider before starting Populus Alba Pollen.
There are few absolute contraindications for drug combinations, but the following are strictly avoided in clinical practice:
For each major interaction, the management strategy involves either discontinuing the interfering drug (beta-blockers) or adjusting the timing of the test/injection (antihistamines).
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including over-the-counter allergy meds.
Populus Alba Pollen must NEVER be used in the following circumstances:
Conditions requiring careful risk-benefit analysis include:
Patients allergic to Populus Alba Pollen often show cross-sensitivity to other members of the Populus genus (e.g., Cottonwoods, Aspens) and the Salix genus (Willows). There is also significant cross-reactivity with Birch pollen (Betula) due to shared proteins like the Bet v 1 homologues. If you are allergic to one of these, you may react to Populus Alba extract even if never previously exposed.
> Important: Your healthcare provider will evaluate your complete medical history and current respiratory health before prescribing Populus Alba Pollen.
Pregnancy Category: C (as per traditional FDA categories). There are no adequate and well-controlled studies in pregnant women.
It is not known whether Populus Alba Pollen allergenic proteins are excreted in human milk. However, since these are large proteins that are processed locally by the immune system, it is highly unlikely that they would reach the milk in any significant or bioactive form. Breastfeeding is generally considered safe for mothers receiving immunotherapy.
Populus Alba Pollen is approved for use in children. Clinical trials and long-term use have shown it to be effective in reducing the development of asthma in children with allergic rhinitis.
In patients over 65, the decision to use Populus Alba Pollen must be individualized.
No dose adjustment is necessary. The proteins in Populus Alba Pollen are not cleared by the kidneys in a way that would lead to accumulation in the setting of renal failure.
No dose adjustment is necessary. The liver does not play a role in the immunological processing or clearance of subcutaneous allergenic extracts.
> Important: Special populations require individualized medical assessment. Always inform your doctor if you become pregnant or are planning to breastfeed while on immunotherapy.
Populus Alba Pollen extract acts as an immunomodulator. In the diagnostic setting, it triggers IgE-mediated mast cell degranulation. In the therapeutic setting, it induces a state of desensitization. The molecular targets are the T-cell receptors and B-cell surface immunoglobulins. By presenting the allergen in a controlled, subcutaneous manner, the extract encourages the immune system to produce IL-10 and TGF-beta from Regulatory T-cells. This leads to a 'class switch' in B-cells from producing IgE (allergic antibody) to IgG4 (blocking antibody).
| Parameter | Value |
|---|---|
| Bioavailability | N/A (Subcutaneous local action) |
| Protein Binding | Primarily to IgE and IgG4 antibodies |
| Half-life | Proteins degraded within hours/days by proteases |
| Tmax | 15-30 minutes for local immune response |
| Metabolism | Proteolytic degradation in immune cells |
| Excretion | Minimal renal excretion of fragments |
Populus Alba Pollen is classified as a Non-Standardized Pollen Allergenic Extract [EPC]. It is grouped with other tree, grass, and weed pollens used in clinical allergy practice. Unlike 'Standardized' extracts, its potency is not measured by a biological skin test assay against a national standard, but by its protein content (PNU).
Common questions about Populus Alba Pollen
Populus Alba Pollen is primarily used for the diagnosis and treatment of allergies to the White Poplar tree. In diagnosis, it is used in skin prick tests to identify if a patient's respiratory symptoms, like sneezing or wheezing, are caused by this specific pollen. In treatment, it is used in allergen immunotherapy, commonly known as allergy shots. This involves giving gradually increasing doses of the pollen extract to help the immune system build up a tolerance. Over time, this can significantly reduce or even eliminate allergy symptoms and the need for other medications.
The most common side effects are localized reactions at the site of the injection. These include redness, itching, and a small raised bump or swelling, which usually appear within minutes and fade within a few hours. Some patients may also experience a 'large local reaction,' where the swelling is bigger than a few inches across. While these local effects are common and usually harmless, they are monitored closely by healthcare providers. Systemic symptoms like hives or hay fever-like congestion can occur but are less frequent than local site reactions.
It is generally recommended to avoid alcohol on the days you receive a Populus Alba Pollen injection. Alcohol can cause your blood vessels to dilate (expand), which might speed up the absorption of the allergen into your bloodstream and potentially increase the risk of a systemic allergic reaction. Furthermore, alcohol can mask the early symptoms of an allergic reaction, such as feeling lightheaded or flushed. To ensure maximum safety during the 24-hour window around your injection, it is best to abstain from alcoholic beverages. Always consult your allergist for their specific policy regarding alcohol and immunotherapy.
The safety of Populus Alba Pollen during pregnancy is a matter of careful risk management. Doctors generally do not start new immunotherapy (allergy shots) during pregnancy because of the risk of a severe allergic reaction, which could deprive the baby of oxygen. However, if a woman is already on a stable maintenance dose and is doing well, many allergists will allow her to continue the treatment. The dose may be kept the same or slightly reduced to ensure safety. Decisions regarding immunotherapy during pregnancy must be made on an individual basis between the patient and her specialist.
Allergen immunotherapy with Populus Alba Pollen is a long-term commitment and does not provide immediate relief like an antihistamine. Most patients begin to notice a reduction in their allergy symptoms during the first 'maintenance' phase, which usually occurs 3 to 6 months after starting the injections. Significant improvement is typically seen after one full year of treatment. For the best results and long-term protection, the treatment is usually continued for 3 to 5 years. If no improvement is seen after 18 months, your doctor may re-evaluate the treatment plan.
Yes, you can stop taking Populus Alba Pollen injections suddenly without experiencing physical withdrawal symptoms, as it is not an addictive substance. However, stopping the treatment before the recommended 3-to-5-year course is finished usually means your allergy symptoms will eventually return. The 'tolerance' your immune system was building may fade if the maintenance phase is not completed. If you need to stop treatment due to side effects, cost, or scheduling issues, you should discuss it with your allergist first. They can help you determine the best way to manage your allergies moving forward.
If you miss a scheduled injection of Populus Alba Pollen, you should contact your allergist's office as soon as possible to reschedule. The procedure for a missed dose depends on how long it has been since your last shot and whether you are in the 'build-up' or 'maintenance' phase. If it has only been a few extra days, you might receive your usual dose. If several weeks have passed, your doctor may need to reduce the dose for safety reasons and then gradually build it back up. Consistency is key to both the safety and effectiveness of the treatment.
There is no clinical evidence to suggest that Populus Alba Pollen extracts cause weight gain. These extracts consist of natural proteins and are administered in very small quantities that do not affect the body's metabolism or appetite. Unlike some other medications used for allergies, such as oral corticosteroids (like prednisone), allergenic extracts do not have systemic hormonal effects. If you experience weight changes while on immunotherapy, it is likely due to other factors and should be discussed with your primary care physician.
Populus Alba Pollen can be taken with many other medications, but there are critical exceptions. You must tell your doctor if you are taking beta-blockers (often used for blood pressure or heart issues), as these can make an allergic reaction much harder to treat. Other drugs like ACE inhibitors and MAOIs also require caution. Interestingly, many patients continue taking their regular allergy medications, like antihistamines or nasal sprays, while receiving shots. These can actually help reduce the minor side effects of the injections during the early stages of treatment.
The concept of 'generic' doesn't apply to allergenic extracts in the same way it does to chemical pills. Populus Alba Pollen is a biological product, and various manufacturers produce their own versions of the extract. While they all contain the same White Poplar pollen proteins, they are 'non-standardized,' meaning the exact concentration of specific proteins can vary between brands. Because of this, allergists generally prefer not to switch between different manufacturers' vials once a patient has started their treatment, as a new vial might be slightly more or less potent.